[go: up one dir, main page]

WO2001021780A3 - Targeted gene removal - Google Patents

Targeted gene removal Download PDF

Info

Publication number
WO2001021780A3
WO2001021780A3 PCT/GB2000/003543 GB0003543W WO0121780A3 WO 2001021780 A3 WO2001021780 A3 WO 2001021780A3 GB 0003543 W GB0003543 W GB 0003543W WO 0121780 A3 WO0121780 A3 WO 0121780A3
Authority
WO
WIPO (PCT)
Prior art keywords
targeted gene
gene removal
transgene
attp
flanking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2000/003543
Other languages
French (fr)
Other versions
WO2001021780A2 (en
Inventor
Peter Meyer
Elena Zubko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leeds
Original Assignee
University of Leeds
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leeds filed Critical University of Leeds
Priority to EP00964384A priority Critical patent/EP1212443A2/en
Priority to CA002384932A priority patent/CA2384932A1/en
Priority to HU0202805A priority patent/HUP0202805A2/en
Priority to AU75325/00A priority patent/AU7532500A/en
Priority to BR0014521-1A priority patent/BR0014521A/en
Priority to JP2001525339A priority patent/JP2003510043A/en
Publication of WO2001021780A2 publication Critical patent/WO2001021780A2/en
Publication of WO2001021780A3 publication Critical patent/WO2001021780A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method of removing a part of a transgene after its integration into a genome comprising flanking the part of the transgene on each side with an attachment P region (attP) of bacteriophage μ and inducing intrachromasomal homologous recombination between the flanking attP regions so that the part of the transgene sandwiched between the attP regions is removed.
PCT/GB2000/003543 1999-09-17 2000-09-15 Targeted gene removal Ceased WO2001021780A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP00964384A EP1212443A2 (en) 1999-09-17 2000-09-15 Targeted gene removal
CA002384932A CA2384932A1 (en) 1999-09-17 2000-09-15 Targeted gene removal
HU0202805A HUP0202805A2 (en) 1999-09-17 2000-09-15 Targeted gene removal
AU75325/00A AU7532500A (en) 1999-09-17 2000-09-15 Targeted gene removal
BR0014521-1A BR0014521A (en) 1999-09-17 2000-09-15 Removal of targeted gene
JP2001525339A JP2003510043A (en) 1999-09-17 2000-09-15 Target gene removal

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921937.0A GB9921937D0 (en) 1999-09-17 1999-09-17 Targeted gens removal
GB9921937.0 1999-09-17

Publications (2)

Publication Number Publication Date
WO2001021780A2 WO2001021780A2 (en) 2001-03-29
WO2001021780A3 true WO2001021780A3 (en) 2001-10-18

Family

ID=10861053

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/003543 Ceased WO2001021780A2 (en) 1999-09-17 2000-09-15 Targeted gene removal

Country Status (10)

Country Link
EP (1) EP1212443A2 (en)
JP (1) JP2003510043A (en)
CN (1) CN1375010A (en)
AU (1) AU7532500A (en)
BR (1) BR0014521A (en)
CA (1) CA2384932A1 (en)
GB (1) GB9921937D0 (en)
HU (1) HUP0202805A2 (en)
RU (1) RU2002108173A (en)
WO (1) WO2001021780A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6580019B1 (en) 2000-03-09 2003-06-17 Dekalb Genetics Corporation Non-reciprocal recombination-mediated transgene deletion in transgenic plants
US6750379B2 (en) 2000-03-09 2004-06-15 Dekalb Genetics Corporation Homologous recombination-mediated transgene alterations in plants
EP1276884A2 (en) * 2000-04-20 2003-01-22 Btg International Limited Transgenic plants
JP2008539766A (en) * 2005-05-17 2008-11-20 オズジーン プロプライアタリー リミテッド Continuous cloning system

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0160571A2 (en) * 1984-04-30 1985-11-06 Biotechnica International, Inc. Cloning vehicle
EP0299552A1 (en) * 1987-06-22 1989-01-18 Solvay A process for transforming cells
WO1991019796A1 (en) * 1990-06-12 1991-12-26 Baylor College Of Medicine Method for homologous recombination in animal and plant cells
WO1994017176A1 (en) * 1993-01-29 1994-08-04 Purdue Research Foundation Controlled modification of eukaryotic genomes
WO1996033269A1 (en) * 1995-04-20 1996-10-24 Medimmune, Inc. Vectors and prokaryotes which autocatalytically delete antibiotic resistance
EP0911412A1 (en) * 1996-05-09 1999-04-28 Nippon Paper Industries Co., Ltd. Vector for gene transfer into plant allowing optional deletion of marker gene
WO1999021977A1 (en) * 1997-10-24 1999-05-06 Life Technologies, Inc. Recombinational cloning using nucleic acids having recombination sites
WO2001007572A2 (en) * 1999-07-23 2001-02-01 The Regents Of The University Of California Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0160571A2 (en) * 1984-04-30 1985-11-06 Biotechnica International, Inc. Cloning vehicle
EP0299552A1 (en) * 1987-06-22 1989-01-18 Solvay A process for transforming cells
WO1991019796A1 (en) * 1990-06-12 1991-12-26 Baylor College Of Medicine Method for homologous recombination in animal and plant cells
WO1994017176A1 (en) * 1993-01-29 1994-08-04 Purdue Research Foundation Controlled modification of eukaryotic genomes
WO1996033269A1 (en) * 1995-04-20 1996-10-24 Medimmune, Inc. Vectors and prokaryotes which autocatalytically delete antibiotic resistance
EP0911412A1 (en) * 1996-05-09 1999-04-28 Nippon Paper Industries Co., Ltd. Vector for gene transfer into plant allowing optional deletion of marker gene
WO1999021977A1 (en) * 1997-10-24 1999-05-06 Life Technologies, Inc. Recombinational cloning using nucleic acids having recombination sites
WO2001007572A2 (en) * 1999-07-23 2001-02-01 The Regents Of The University Of California Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
D'ENFERT C: "Selection of multiple disruption events in Aspergillus fumigatus using the orotidine-5'-decarboxylase gene, pyrG, as a unique transformation marker", CURRENT GENETICS,US,NEW YORK, NY, vol. 30, no. 1, June 1996 (1996-06-01), pages 76 - 82, XP002107254, ISSN: 0172-8083 *
HORIE K ET AL: "A replacement vector used to introduce subtle mutations into mouse genes", GENE,NL,ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, vol. 166, no. 2, 1995, pages 197 - 204, XP004043073, ISSN: 0378-1119 *
OW D W ET AL: "GENOME MANIPULATION THROUGH SITE-SPECIFIC RECOMBINATION", CRITICAL REVIEWS IN PLANT SCIENCES,US,CRC PRESS, BOCA RATON, FL, vol. 14, no. 3, 1995, pages 239 - 261, XP000614883, ISSN: 0735-2689 *
PEREDELCHUK M Y ET AL: "A method for construction of E. coli strains with multiple DNA insertions in the chromosome", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES,GB,ELSEVIER SCIENCE PUBLISHERS, BARKING, vol. 187, no. 2, 18 March 1997 (1997-03-18), pages 231 - 238, XP004093285, ISSN: 0378-1119 *
YODER J I ET AL: "TRANSFORMATION SYSTEMS FOR GENERATING MARKER-FREE TRANSGENIC PLANTS", BIO/TECHNOLOGY,US,NATURE PUBLISHING CO. NEW YORK, vol. 12, no. 3, 1 March 1994 (1994-03-01), pages 263 - 267, XP002043802, ISSN: 0733-222X *
ZUBKO ELENA ET AL: "Intrachromosomal recombination between attP regions as a tool to remove selectable marker genes from tobacco transgenes.", NATURE BIOTECHNOLOGY, vol. 18, no. 4, April 2000 (2000-04-01), pages 442 - 445, XP002165150, ISSN: 1087-0156 *

Also Published As

Publication number Publication date
AU7532500A (en) 2001-04-24
WO2001021780A2 (en) 2001-03-29
RU2002108173A (en) 2004-03-10
JP2003510043A (en) 2003-03-18
GB9921937D0 (en) 1999-11-17
CN1375010A (en) 2002-10-16
CA2384932A1 (en) 2001-03-29
HUP0202805A2 (en) 2002-12-28
EP1212443A2 (en) 2002-06-12
BR0014521A (en) 2002-06-11

Similar Documents

Publication Publication Date Title
EP0918877A4 (en) Methods for isolating nucleic acids using alkaline protease
AU3890795A (en) Improved method for nucleotide sequence amplification
AU4774196A (en) Method for suppressing dna fragment amplification during pcr
AU2002241479A1 (en) A system and process for mediated crawling
EP1167377A3 (en) Immunomodulatory oligonucleotides
AU2187295A (en) Cleaved amplified rflp detection methods
AU4134001A (en) Methods for treating conditions and illnesses associated with abnormal vasculature
EP1054069A4 (en) Multi-function lance for a vacuum degassing chamber and a method of using the same
AU1591600A (en) Manipulator and method for manufacturing the manipulator and method for putting into operation of the manipulator
WO2001021780A3 (en) Targeted gene removal
AU3488699A (en) Surface treatment process and system
CA2427826A1 (en) Method and system for safe device reconfiguration
GB9823563D0 (en) Graffiti removing method
CA2278808A1 (en) Methods for cultivating cells and propagating viruses
AU4433299A (en) Genotyping the human phenol sulfotransferase 2 gene (stp2)
AU3006899A (en) Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment
AUPP282898A0 (en) Treatment of waste materials
MXPA02002565A (en) Processes for making protein hydrolysates from animal peptone and for preserving mucosa.
AU4566097A (en) Bale handling apparatus
AUPP536598A0 (en) Organic impurity removal process for bayer liquors
AU3229695A (en) Intermediates for dinucleotide and oligonucleotide analogues
DE68908377D1 (en) PHOSPHORIC SURFACE TREATMENT AND METHOD FOR A CATHODE JET PIPE.
EP1352039A4 (en) Hydroprocessing process with integrated interstage stripping
MXPA01011741A (en) Tire shredding machine and method of using the same.
EP1018875A4 (en) Insecticidal peptides from segestria sp. spider venom

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 75325/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000964384

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2384932

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 525339

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 00813040X

Country of ref document: CN

ENP Entry into the national phase

Ref country code: RU

Ref document number: 2002 2002108173

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000964384

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000964384

Country of ref document: EP